Liquid

Description

The drug is identified by SPL Code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with the letter "A" on one side and the number "1" on the opposite side. Each tablet contains 1 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and color additives.

Uses and Indications

This drug is indicated for the treatment of acne. It aids in preventing the formation of new acne blemishes.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use. The application should begin on damp skin. A small amount of the product should be dispensed onto the fingertips and emulsified. The patient should then gently cleanse the skin using circular motions to ensure even distribution and effective cleansing. After cleansing, the skin should be rinsed thoroughly with warm water, followed by gently patting the skin dry with a soft towel. It is recommended to follow this cleansing process with the MONAT Skincare Routine for optimal results.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to adhere to the following precautions:

In the event of accidental ingestion, seek medical assistance or contact a poison control center immediately. Additionally, avoid contact with the eyes; if contact occurs, rinse the eyes thoroughly with water.

Warnings and Precautions

For external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a poison control center immediately.

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To minimize the potential for adverse effects, it is recommended that only one topical acne treatment be utilized at a time. Should irritation occur, discontinue use of all topical acne treatments and consult a healthcare professional.

Care should be taken to avoid contact with the eyes. In the event of contact, it is essential to rinse the eyes thoroughly with water to mitigate any potential irritation or damage.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in clinical trials or postmarketing experiences.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne treatment be utilized at a time. If irritation occurs, discontinuation of additional topical treatments is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne medications.

Packaging & NDC

Below are the non-prescription pack sizes of Liquid (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, it is crucial to seek medical assistance or contact a poison control center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly, and alternative treatments may be considered in the absence of established safety profiles.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of specific antidotes or treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the substance, amount ingested, and time of ingestion, is crucial for effective management and treatment planning.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a poison control center if the product is swallowed. It is crucial for patients to understand the potential risks associated with ingestion and the importance of prompt action.

Healthcare providers should inform patients that the likelihood of skin irritation and dryness may increase if they use another topical acne medication concurrently. Patients should be counseled to use only one topical acne treatment at a time to minimize the risk of irritation.

Additionally, patients must be cautioned to avoid contact with the eyes. In the event that the product comes into contact with the eyes, they should rinse their eyes thoroughly with water to alleviate any potential discomfort or adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. In the event of irritation, it is recommended that only one topical acne treatment be utilized at a time. Patients should also be cautioned to avoid contact with the eyes; if contact occurs, they should rinse their eyes thoroughly with water. Additionally, the product should be kept out of reach of children, and if ingested, medical assistance or contact with a poison control center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)